Treatment of Facial Lipoatrophy via AutologousFat Transfer

May 2009 | Volume 8 | Issue 5 | Original Article | 486 | Copyright © 2009

George Cohen MD and Annyce Treherne MD


The advent of highly active anti-retroviral therapy (HAART) has extended the lives of patients affected by human immunodeficiency virus (HIV) disease. A common cutaneous side effect of HAART is facial lipoatrophy. The hollowed out cheeks, temples and eye sockets often lead to a gaunt cachetic facies which can be a disconcerting stigmata of the disease and a psychological burden to the patient. Autologous fat transfer (ATF) is a minimally invasive surgical procedure that can temporarily improve the appearance in patients with facial lipoatrophy. Other corrective procedures (e.g., injectable fillers) are available, but, to date, the ideal procedure for permanent correction of facial lipoatrophy has not been found.

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close

Related Articles